Fixed-Dose Factor Eight Inhibitor Bypassing Activity (FEIBA) in the Management of Warfarin-Associated Coagulopathies

• Main Authors: Francisco Ibarra (Author), Mallory Cruz (Author), Matthew Ford (Author), Meng-Jou Wu (Author)
• Format: Bog
• Udgivet: MDPI AG, 2022-04-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

This retrospective review evaluated our institutions' practice of administering low fixed-dose FEIBA (high (1000 units) or low dose (500 units) for an INR ≥ 5 or <5, respectively) for the management of warfarin-associated coagulopathies. The primary outcome was the percentage of patients who...